3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, Follicular
2
Lymphoma
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Thrombocytopenia
1
Splenomegaly
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphocytosis
1
Lymphadenopathy
1
Lung Neoplasms
1
Kidney Neoplasms
1
Insulin Resistance
1
Immunoblastic Lymphadenopathy
1
Hyperglycemia
1
Hodgkin Disease
1
Interventions
Cyclophosphamide
73
fludarabine phosphate
42
Filgrastim
38
Peripheral Blood Stem Cell Transplantation
35
Radiotherapy
33
Cyclosporine
32
Busulfan
32
Mycophenolic Acid
30
Etoposide
29
Antilymphocyte Serum
28
Whole-Body Irradiation
26
Methotrexate
25
Melphalan
21
Methylprednisolone
20
Rituximab
19
Vincristine
17
Tacrolimus
17
Cytarabine
17
Cord Blood Stem Cell Transplantation
17
Doxorubicin
14
Prednisone
13
Thiotepa
10
Granulocyte Colony-Stimulating Factor
9
Leucovorin
7
Carboplatin
7
fludarabine
6
aldesleukin
6
sargramostim
5
Sirolimus
5
Psychiatric Rehabilitation
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Metformin
×
Lymphoid
×
Clear all
NCT02531308
2022-09-28
DLBCL
Rush University Medical Center
Phase 2
Terminated
5 enrolled
5 charts